Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
nd-l02-s0201 (1 trial)
Fibrosis (Phase 1)
Trials (1 total)
Trial APIs (1 total)